Everest Organics Share Price
272.60+0.70 (+0.26%)
-29.19% past 1 Year
Everest Organics Ltd was incorporated on 19.02.1993 to carry on the business of manufacturing of bulk drugs viz. Omeprazole, Ciprofloxacin, Dichloroflurobenzene, Benzimadizole, etc., having its factory at Sadasivpet Medak District
Corporate filings & documents
Announcements
News Paper publications of Un-audited Financial Results for the Quarter ended June 30 2026
2 weeks agoNews Paper publications of Un-audited Financial Results for the Quarter ended June 30 2026
2 weeks agoEnclosed
2 weeks agoEnclosed
2 weeks agoEnclosed
2 weeks agoEnclosed
2 weeks agoEnclosed
2 weeks agoEnclosed
2 weeks agoAppointment of Mr. Subroto Banerjee as Additional Director of the Company in the Independent Category w.e.f. August 14 2026
2 weeks agoAppointment of Mr. Subroto Banerjee as Additional Director of the Company in the Independent Category w.e.f. August 14 2026
2 weeks agoAppointment of Mr. Srikanth Reddy Kolli as Additional Director in the Independent Category w.e.f. August 14 2026
2 weeks agoAppointment of Mr. Srikanth Reddy Kolli as Additional Director in the Independent Category w.e.f. August 14 2026
2 weeks agoEnclosed
2 weeks agoEnclosed
2 weeks agoEnclosed
2 weeks agoEnclosed
2 weeks agoEverest Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Board Meeting is scheduled to be held on Friday August 14 2026 to consider the business as mentioned in the attached Intimation.
4 weeks agoEverest Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Board Meeting is scheduled to be held on Friday August 14 2026 to consider the business as mentioned in the attached Intimation.
4 weeks agoThe Board of Directors approved by way of Circular Resolution on July 11 2026 the Allotment of 263157 fully paid-up equity shares of Rs. 10 each at a price of Rs. 152 each upon conversion of an equal number of convertible warrants held by Dr. Sirisha Srikakarlapudi Managing Director & Promoter of the Company on receipt of balance 75% consideration of Rs. 2 99 99 898.
1 month agoThe Board of Directors approved by way of Circular Resolution on July 11 2026 the Allotment of 263157 fully paid-up equity shares of Rs. 10 each at a price of Rs. 152 each upon conversion of an equal number of convertible warrants held by Dr. Sirisha Srikakarlapudi Managing Director & Promoter of the Company on receipt of balance 75% consideration of Rs. 2 99 99 898.
1 month agoIntimation of trading window closure for the quarter ended June 30 2026.
2 months agoIntimation of trading window closure for the quarter ended June 30 2026.
2 months agoResignation of Ms. Shweta Singh from the position of Company Secretary & Compliance Officer of the Company w.e.f. June 22 2026.
2 months agoResignation of Ms. Shweta Singh from the position of Company Secretary & Compliance Officer of the Company w.e.f. June 22 2026.
2 months agoNewspaper publication of Audited Financial Results for the quarter and year ended March 31 2026.
3 months agoAppointment of Mr. Narra Venkata Ramana as Additional Director in the Board Meeting held today i.e. May 29 2026.
3 months agoAppointment of Mr. Narra Venkata Ramana as Additional Director in the Board Meeting held today i.e. May 29 2026.
3 months agoOutcome of the Board Meeting held today .i.e. May 29 2026.
3 months agoOutcome of the Board Meeting held today .i.e. May 29 2026.
3 months agoAudited Financial Results for quarter and year ended March 31 2026.
3 months agoEnclosed the Annual Secretarial Compliance Report of the Company issued by M/s. RPR & Associates Practising Company Secretaries for the Fianancial Year ended March 31 2026.
3 months agoEnclosed the Annual Secretarial Compliance Report of the Company issued by M/s. RPR & Associates Practising Company Secretaries for the Fianancial Year ended March 31 2026.
3 months agoEverest Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve a) to consider and approve the Audited (Standalone) Financial Results of the Company for the quarter and year ended March 31 2026 b) to consider and take note of the draft Report of Statutory Auditor for the financial year ended March 31 2026.
3 months agoSubmission of certificate under Reg. 74(5) of SEBI (DP) Regulation for the quarter ended March 31 2026.
4 months agoSubmission of certificate under Reg. 74(5) of SEBI (DP) Regulation for the quarter ended March 31 2026.
4 months agoNewspaper publication- Special window for transfer and dematerialization of physical securities.
5 months agoNewspaper publication- Special window for transfer and dematerialization of physical securities.
5 months agoClosure of Trading Window
5 months agoClosure of Trading Window
5 months agoDisclosure of reason for delay in submission of financial results for the quarter ended December 31 2025.
6 months agoDisclosure of reason for delay in submission of financial results for the quarter ended December 31 2025.
6 months agoNewspaper Advertisement for publication of Unaudited financials results for the quarter and nine months ended December 31 2025
6 months agoEverest Organics Limited submitted the unaudited financial results for the quarter and nine months ended December 31 2025.
6 months agoEverest Organics Limited submitted exchange unaudited financials results for the quarter and nine months ended December 31 2025.
6 months agoEverest Organics Limited submitted exchange unaudited financials results for the quarter and nine months ended December 31 2025.
6 months agoCopy of newspaper publication.
6 months agoCopy of newspaper publication.
6 months agoEverest Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve i. Un-Audited Financial Results along with the limited review report of the Company for the Quarter ended December 31 2026.ii. Other business transactions.
6 months agoEverest Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve i. Un-Audited Financial Results along with the limited review report of the Company for the Quarter ended December 31 2025.ii. Other business transactions.
7 months agoReport on re-lodgement of transfer request of physical shares.
7 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
Aroor Village Sadasivpet Mandal Sanga Reddy Medak Dist Telangana PIN: 502291 Tel No: 08455-250186, 250113, 250115 Fax No: 08455-250114 Email: [email protected] Internet: www.everestorganicsltd.com
Registrars
Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57, 4th & 5th Floors, Jayabheri Enclave Phase - II, Gachibowli(Old Address:12-10-167, MIG- 167,Bharat Nagar Colony, Hyderabad – 500018.)Phone: +91-40-23818475/6Fax : +91-40-23868024Email: info@vccili Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57 4th & 5th Floors Jayabheri Enclave Phase - II, Gachibowli PIN: Tel No: 23818475,23868257,35164910 Fax No: NULL Email: [email protected] Internet: www.vccipl.com
Management
Prasad Venkata Satya Sundara Srikakolapu, Chairman
Sri Kakarlapudi Sirisha, Managing Director
Srikakarlapudi Harikrishna, Whole Time Director
Kirankumar Rampally, Non Independent & Non Executive Director
Venkata Satyanarayana Murthy Vadali, Non Executive Independent Director
Details
BSE 524790
NSE NULL
ISIN INE334C01029